CMS Reopens NCD for PET
by Laurence Wooster | July 04, 2007
Following a request from Abass Alavi, MD, professor of radiology and chief of nuclear medicine at the University of Pennsylvania, Philadelphia, and Javad Parvazi, MD, associate professor of orthopedic surgery at Thomas Jefferson University, Philadelphia, the Centers for Medicare and Medicaid Services (CMS) will reconsider the current Medicare coverage for PET according to section 220.6 of the National Coverage Determination (NCD) Manual.
Specifically, Medicare will consider covering PET used for the diagnosis of chronic osteomyelitis, infections associated with hip arthroplasty and fever of unknown origin, in lieu of bone, leukocyte and/or gallium scintigraphy.
Review was initiated on June 25; the public comment period ends July 25, 2007, and the expected national coverage analysis (NCA) completion date is March 24, 2008.
Reprinted from the Imaging Economics Advisor.
Specifically, Medicare will consider covering PET used for the diagnosis of chronic osteomyelitis, infections associated with hip arthroplasty and fever of unknown origin, in lieu of bone, leukocyte and/or gallium scintigraphy.
Review was initiated on June 25; the public comment period ends July 25, 2007, and the expected national coverage analysis (NCA) completion date is March 24, 2008.
Reprinted from the Imaging Economics Advisor.
